Clinical trial Recruiting at 13 sites Interventional Ages 18 and up

Exercise to improve outcomes in colorectal cancer patients

Official title: Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome (AMICO). The Effects of Exercise on Chemotherapy Dose Modification and Progression Free Survival in Patients With Metastatic Colorectal Cancer

Run by Radboud University Medical Center · NCT04754672 · Data updated 2026-11-12

This study is testing whether aerobic and resistance exercise can help people with metastatic colorectal cancer feel better and handle chemotherapy without needing to change their treatment.

More Colorectal Cancer trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment228 (estimated)
SponsorRadboud University Medical Center
Academic / other
Drugs / interventionschemotherapy
Locations13 sites ('s-Hertogenbosch and 12 other locations)
StatusRecruiting
StartedMarch 2, 2021
Main results expectedMarch 2026
Study endsDecember 2026
Registry record updatedNovember 18, 2023
Trial IDNCT04754672 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with metastatic colorectal cancer who are scheduled for first-line palliative chemotherapy.

Probably not a fit

Patients with a life expectancy of less than six months or those unable to perform basic daily activities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of aerobic and resistance exercise on patients with metastatic colorectal cancer undergoing palliative chemotherapy. It aims to determine whether exercise can reduce chemotherapy-related toxicity and prevent dose modifications, which are common in this patient population. The study will compare different types of exercise interventions to identify the optimal approach for enhancing physical fitness and quality of life during treatment. By exploring the relationship between exercise and cancer outcomes, the research seeks to provide evidence for integrating exercise into standard cancer care.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment outcomes and quality of life for colorectal cancer patients undergoing chemotherapy.

How similar studies have gone: Previous studies have shown positive effects of exercise on cancer treatment outcomes, but this specific approach is novel and aims to clarify optimal exercise prescriptions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* mCRC with indication for palliative chemotherapy
* scheduled for treatment with first-line doublet or triplet chemotherapy, according to the national guideline
* able and willing to give written informed consent.

Exclusion Criteria:

* life expectancy \<6 months
* unable to perform basic activities of daily living such as walking or biking
* presence of cognitive disorders or severe emotional instability (e.g., Schizophrenia, Alzheimer, alcohol addiction);
* presence of other disabling co-morbidities that might hamper physical exercise (e.g. heart failure (NYHA classes 3 and 4), chronic obstructive pulmonary disease (COPD, gold 3 and 4), orthopaedic conditions and neurological disorders (e.g., hernia, paresis, amputation, active rheumatoid arthritis);
* insufficient mastery of the Dutch language;
* presence of serious cardiovascular or cardiopulmonary conditions (e.g. unstable angina, arrhythmia or valve disease) such that exercise safety is at risk, as judged by the treating physician.
* Already participating in structured vigorous aerobic and/or resistance exercise ≥ 2 times per week comparable to our intervention

Where it's running

  • Jeroen Bosch Ziekenhuis
    's-Hertogenbosch, Netherlands
    Recruiting
  • Flevoziekenhuis
    Almere Stad, Netherlands
    Recruiting
  • Meander Medisch Centrum
    Amersfoort, Netherlands
    Recruiting
  • Ziekenhuis Amstelland
    Amstelveen, Netherlands
    Recruiting
  • Amsterdam UMC
    Amsterdam, Netherlands
    Recruiting
  • Netherlands Cancer Institute
    Amsterdam, Netherlands
    Recruiting
Show 7 more locations
  • Rijnstate Ziekenhuis
    Arnhem, Netherlands
    Recruiting
  • Ziekenhuis Amphia
    Breda, Netherlands
    Recruiting
  • Catharina Ziekenhuis
    Eindhoven, Netherlands
    Recruiting
  • Spaarne Gasthuis
    Hoofddorp, Netherlands
    Recruiting
  • Radboudumc
    Nijmegen, Netherlands
    Recruiting
  • Canisius Wilhelmina Ziekenhuis
    Nijmegen, Netherlands
    Recruiting
  • Umcu
    Utrecht, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.